TRAVERE THERAPEUTICS, INC.: capex
| Value | {"amount": 117033, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2013-01-01 – 2013-12-31 |
| Status | superseded |
| Entity | TRAVERE THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:10:32.965170+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/53ba7d04-d298-4969-9c09-c7ceb02ee347
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193805-14-000650Retrieved: 2026-08-19T14:10:32.965170+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001438533/capex/2013-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/53ba7d04-d298-4969-9c09-c7ceb02ee347
History
- no predecessors — first report